YSM Issue 93.2
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NANOMOLDED
INTO PERFECTION
SCIENTISTS DISCOVER NOVEL WAY
TO PRODUCE NANOMATERIALS
BY ATHENA STENOR
ILLUSTRATION COURTESY OF ELLI E GABRIEL
Increasingly today, nanotechnology is coming into our lives,
allowing us to design more efficient batteries, build lightweight
vehicles, and even administer needleless vaccines. However, a
major barrier to accessing the full potential of nanoscale materials
is their fabrication. A team of researchers from Yale University and
Wuhan University recently discovered that thermomechanical
nanomolding is a reliable method for the nanofabrication of
ordered phases (OPs).
OPs, a class of materials consisting of sublattices occupied by
atoms, are fundamental to various functional applications. Most
functional materials, including superconductors, magnetic materials
and plasmonic materials, belong to this class. Creating nanoscale
OPs is challenging because traditional techniques, such as chemical
vapor deposition growth, are not practical. For example, chemical
vapor deposition growth, a technique in which a film of vaporized,
decomposing chemical is deposited onto a substrate’s surface, only
works for easily vaporized OPs and cannot produce certain shapes.
But thermomechanical nanomolding can be scaled up for mass
production, fine-tuned to obtain specific characteristics, and used
with a variety of starting materials. In this technique, raw material was
pushed into a nanomold at steady pressure and a temperature below
its melting point, to produce single-crystalline nanowires of consistent
composition and structure. The process could be tuned so that the
nanowires’ aspect ratios were high, enabling easier access to different
morphologies. The researchers attribute their results to OPs’ tendency
to self-organize via a thermodynamic (stability-driven) rather than
kinetic (speed-driven) mechanism. This new process will make OPs a
more accessible class of nanomaterials, and enable the development of
exciting new applications for nanotechnology. ■
Liu, N., Xie., Y., Liu, G., Sohn, S., Raj, A., Han, G., Wu, B., Cha,
J.J., Liu, Z., & Schroers, J. (2020). General Nanomolding of
Ordered Phases. Physical Review Letters, 124(3). https://doi.
org/10.1103/physrevlett.124.036102
IMPLICATIONS
OF IMPELLA
RETHINKING TREATMENTS FOR
CARDIOGENIC SCHOCK
BY MIA JACKSON
ILLUSTRATION COURTESY OF NOORA SAID
More than one million Americans have a heart attack each
year. Four to twelve percent of these patients develop
cardiogenic shock, a condition that prevents one’s heart
from pumping the blood necessary to meet the body’s needs.
Two common treatments for cardiogenic shock include the
left ventricular assist device (LVAD) and the intra-aortic balloon
pump (IABP). While LVADs are more commonly used, Yale
University researchers recently reported the results of a study
examining the discrepancies in in-hospital clinical outcomes
between the two devices.
The study found that LVADs were associated with higher inhospital
mortality and in-hospital major bleeding. “Because there
is relatively little evidence in this area, we think that the analysis
that we did, and the conclusion that we made … would have
both policy implications and regulatory implications,” explained
Nihar Desai, an assistant professor at the Yale School of Medicine
who worked on this study.
Given the two-and-a-half-fold increase in the utilization of
LVADs between 2015 and 2017, Desai’s research suggests that
hospitals might need to rethink treatment plans for cardiogenic
shock. “We hope everyone is trying to integrate these data into
their practice, as it is on everyone to be a little more judicious of
[LVADs], given little evidence that would support their use,” Desai
said. Hopefully, this research will influence the way many doctors
treat cardiogenic shock patients. After all, for every patient that
enters the emergency room, the most common treatment option
available should be the best one for them. ■
Desai, N.R. (2020). Association of Use of an Intravascular
Microaxial Left Ventricular Assist Device vs Intra-aortic
Balloon Pump With In-Hospital Mortality and Major
Bleeding Among Patients With Acute Myocardial Infarction
Complicated by Cardiogenic Shock. JAMA, 323(8), 734–45.
https://doi.org/10.1001/jama.2020.0254
6 Yale Scientific Magazine September 2020 www.yalescientific.org